Select Medical Holdings Corporation Common Stock (NY:SEM)

16.51 UNCHANGED

Last Price Updated: 7:00 PM EDT, Jun 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Select Medical Holdings Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

3 Growth Stocks in Hot Water

March 19, 2025

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who...

Via StockStory

3 Reasons SEM is Risky and 1 Stock to Buy Instead

March 14, 2025

The past six months haven’t been great for Select Medical. It just made a new 52-week low of $15.71, and shareholders have lost 55.5% of their capital. This was partly due to its softer quarterly...

Via StockStory

Delta Air Lines Lowers Q1 Outlook, Joins Asana, Redwire And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

March 11, 2025

Via Benzinga

3 Healthcare Stocks Skating on Thin Ice

February 28, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,...

Via StockStory

Topics Stocks

Earnings Scheduled For February 20, 2025 ↗

February 20, 2025

Via Benzinga

How Is The Market Feeling About Select Medical Hldgs? ↗

January 17, 2025

Via Benzinga

Price Over Earnings Overview: Select Medical Hldgs ↗

January 09, 2025

Via Benzinga

agilon health (AGL) Reports Earnings Tomorrow: What To Expect

February 24, 2025

Healthcare services company Agilon Health (NYSE:AGL) will be reporting earnings tomorrow after market close. Here’s what to look for.

Via StockStory

Why Select Medical (SEM) Shares Are Trading Lower Today

February 21, 2025

Shares of healthcare services company Select Medical (NYSE:SEM) fell 14.1% in the morning session after the company reported disappointing fourth quarter 2024 results, which missed across all key...

Via StockStory

Wondering what's happening in today's after-hours session? ↗

February 20, 2025

As the regular session of the US market on Thursday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

Select Medical (NYSE:SEM) Misses Q4 Sales Targets, Stock Drops

February 20, 2025

Healthcare services company Select Medical (NYSE:SEM) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 20.9% year on year to $1.31 billion. The company’s full-year...

Via StockStory

Topics Artificial Intelligence

4 Analysts Assess Select Medical Hldgs: What You Need To Know ↗

January 03, 2025

Via Benzinga

(SEM) - Analyzing Select Medical Hldgs's Short Interest ↗

November 27, 2024

Via Benzinga

Select Medical (SEM) Reports Q4: Everything You Need To Know Ahead Of Earnings

February 19, 2025

Healthcare services company Select Medical (NYSE:SEM) will be reporting results tomorrow afternoon. Here’s what you need to know.

Via StockStory

Select Medical Holdings Stock Sees RS Rating Jump To 81 ↗

December 23, 2024

On Monday, Select Medical Holdings stock reached a key technical benchmark, seeing its RS Rating jumping to 81, up from 76 the day before.

Via Investor's Business Daily

US Physical Therapy Positioned For Success Despite Medicare Challenges, Analyst Optimistic On Unique Growth Strategy ↗

December 17, 2024

JMP Securities initiates U.S. Physical Therapy (USPH) coverage with a $113 target, citing growth driven by acquisitions, partnerships, and strategic focus.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 26, 2024

Via Benzinga

In-Depth Examination Of 4 Analyst Recommendations For Select Medical Hldgs ↗

November 25, 2024

Via Benzinga

Peering Into Select Medical Hldgs's Recent Short Interest ↗

November 06, 2024

Via Benzinga

Peering Into Select Medical Hldgs's Recent Short Interest ↗

October 07, 2024

Via Benzinga

Analyst Ratings For Select Medical Hldgs ↗

September 06, 2024

Via Benzinga

Amazon Posts Upbeat Results, Joins Cardinal Health, Waters, Atlassian, Charter Communications, MasTec And Other Big Stocks Moving Higher On Friday ↗

November 01, 2024

Via Benzinga

Concentra's Post-IPO Trading Levels Based On 'Its Dominant Market Position,' Says Analyst ↗

August 20, 2024

Concentra, a subsidiary of select medical, recently priced its IPO at $23.50 per share. Concentra offers occupational health services with 547 centers in 41 states.

Via Benzinga

Topics Initial Public Offering

Key Takeaways From Select Medical Hldgs Analyst Ratings ↗

August 20, 2024

Via Benzinga

Peering Into Select Medical Hldgs's Recent Short Interest ↗

August 05, 2024

Via Benzinga

Demystifying Select Medical Hldgs: Insights From 4 Analyst Reviews ↗

August 02, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Select Medical Hldgs Through 4 Analysts ↗

July 16, 2024

Via Benzinga

SEM Stock Earnings: Select Medical Hldgs Misses EPS, Beats Revenue for Q2 2024 ↗

August 01, 2024

SEM stock results show that Select Medical Hldgs missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

Opening Day: Lineage Goes Public In Largest 2024 IPO ↗

July 28, 2024

Lineage jumped as much as 5% in their debut on the Nasdaq earlier this week. The largest temperature-controlled warehouse real estate investment trust in the world raised $4.4B at an implied valuation...

Via Talk Markets

Topics Initial Public Offering

The 3 Most Undervalued Under-$50 Stocks to Buy in July 2024 ↗

July 09, 2024

A full-throated bull market makes it tough to find undervalued stocks under $50, but these three could soon lead the charge higher.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.